Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer

被引:11
|
作者
Lafont, Elodie [1 ,2 ]
机构
[1] Univ Rennes, INSERM, U1242, F-35042 Rennes, France
[2] Ctr Lutte Canc Eugene Marquis, F-35042 Rennes, France
关键词
death receptor; ER stress; unfolded protein response; TRAIL-R1; 2; CD95; TNFR1; post-translational modifications; cell death; IRE1; PERK; TUMOR-NECROSIS-FACTOR; ENDOPLASMIC-RETICULUM STRESS; APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; TRAIL-INDUCED APOPTOSIS; ISOLATED LIMB PERFUSION; SOLUBLE FAS LIGAND; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; HUMAN-MELANOMA CELLS; ER-STRESS;
D O I
10.3390/cancers12051113
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Throughout tumour progression, tumour cells are exposed to various intense cellular stress conditions owing to intrinsic and extrinsic cues, to which some cells are remarkably able to adapt. Death Receptor (DR) signalling and the Unfolded Protein Response (UPR) are two stress responses that both regulate a plethora of outcomes, ranging from proliferation, differentiation, migration, cytokine production to the induction of cell death. Both signallings are major modulators of physiological tissue homeostasis and their dysregulation is involved in tumorigenesis and the metastastic process. The molecular determinants of the control between the different cellular outcomes induced by DR signalling and the UPR in tumour cells and their stroma and their consequences on tumorigenesis are starting to be unravelled. Herein, I summarize the main steps of DR signalling in relation to its cellular and pathophysiological roles in cancer. I then highlight how the UPR and DR signalling control common cellular outcomes and also cross-talk, providing potential opportunities to further understand the development of malignancies.
引用
收藏
页数:32
相关论文
共 50 条
  • [31] Role of the unfolded protein response in cell death
    R. Kim
    M. Emi
    K. Tanabe
    S. Murakami
    Apoptosis, 2006, 11 : 5 - 13
  • [32] Role of the unfolded protein response in cell death
    Kim, R
    Emi, M
    Tanabe, K
    Murakami, S
    APOPTOSIS, 2006, 11 (01) : 5 - 13
  • [33] Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate
    Corazzari, Marco
    Gagliardi, Mara
    Fimia, Gian Maria
    Piacentini, Mauro
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [34] Controlling the unfolded protein response-mediated life and death decisions in cancer
    Maurel, Marion
    McGrath, Eoghan P.
    Mnich, Katarzyna
    Healy, Sandra
    Chevet, Eric
    Samali, Afshin
    SEMINARS IN CANCER BIOLOGY, 2015, 33 : 57 - 66
  • [35] The unfolded protein response at the crossroads of cellular life and death during endoplasmic reticulum stress
    Jaeger, Richard
    Bertrand, Mathieu J. M.
    Gorman, Adrienne M.
    Vandenabeele, Peter
    Samali, Afshin
    BIOLOGY OF THE CELL, 2012, 104 (05) : 259 - 270
  • [36] Yokukansan Inhibits Neuronal Death during ER Stress by Regulating the Unfolded Protein Response
    Hiratsuka, Toru
    Matsuzaki, Shinsuke
    Miyata, Shingo
    Kinoshita, Mitsuhiro
    Kakehi, Kazuaki
    Nishida, Shinji
    Katayama, Taiichi
    Tohyama, Masaya
    PLOS ONE, 2010, 5 (10):
  • [37] Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma
    Guo, Li
    Dou, Yuyang
    Yang, Yifei
    Zhang, Shiqi
    Kang, Yihao
    Shen, Lulu
    Tang, Lihua
    Zhang, Yaodong
    Li, Changxian
    Wang, Jun
    Liang, Tingming
    Li, Xiangcheng
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 5722 - 5734
  • [38] The unfolded protein response and integrated stress response to anoxia
    Rzymski, Tomasz
    Harris, Adrian L.
    CLINICAL CANCER RESEARCH, 2007, 13 (09) : 2537 - 2540
  • [39] Dicarbonyl stress, protein glycation and the unfolded protein response
    Rabbani, Naila
    Xue, Mingzhan
    Thornalley, Paul J.
    GLYCOCONJUGATE JOURNAL, 2021, 38 (03) : 331 - 340
  • [40] Protein folding, oxidative stress, and the unfolded protein response
    Kaufman, R. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 : S4 - S5